US Healthcare Journal
SEE OTHER BRANDS

Get your fresh news on healthcare and wellness in the United States

US Healthcare Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on US Healthcare Journal.

Press releases published on March 7, 2025

ALIEN EVENT COSMIC COMMAND

ALIEN EVENT COSMIC COMMAND

ALIEN EVENT APRIL 4-6, 2025 Sonesta Los Angeles Airport LAX, 5985 W. Century Blvd, Los Angeles, CA 90045. ET DISCLOSURE, SECRET SPACE, UFOLOGY LOS ANGELES, CA, UNITED STATES, March 7, 2025 /⁨EINPresswire.com⁩/ -- ALIEN EVENT LOS ANGELES 2025 APRIL 4- …

Paul L. Gregory, DDS, Offers Premium Teeth Cleaning Manhattan and New York City

Paul L. Gregory, DDS, Offers Premium Teeth Cleaning Manhattan and New York City

NEW YORK, NY, UNITED STATES, March 7, 2025 /⁨EINPresswire.com⁩/ -- Keeping your smile healthy and radiant has never been easier with the professional dental services at Paul L. Gregory, DDS. Conveniently located in Midtown Manhattan, Dr. Gregory provides …

Dr. Amer Smajkic At Chicago Child Psychiatry Associates Wins 2025 ThreeBestRated® Award

Dr. Amer Smajkic At Chicago Child Psychiatry Associates Wins 2025 ThreeBestRated® Award

CHICAGO, IL, UNITED STATES, March 7, 2025 /⁨EINPresswire.com⁩/ -- ThreeBestRated®, a multi-national ranking organization, has released their annual updates recently. As per their updates, Psychiatrist, Dr. Amer Smajkic at Chicago Child Psychiatry …

Malatya Apricot | Conventional and Sun Dried Apricots From Turkey

Malatya Apricot | Conventional and Sun Dried Apricots From Turkey

Malatya Apricots are the finest dried apricots available in the world. Their rich taste, health benefits, and premium quality make them a preferred choice MALATYA, BATTALGAZI, TURKEY, March 7, 2025 /⁨EINPresswire.com⁩/ -- Malatya, located in eastern …

Coach Keith Engelhardt of Sawatch Solutions Recently Featured on Close Up Radio

Coach Keith Engelhardt of Sawatch Solutions Recently Featured on Close Up Radio

DAYTON, OH, UNITED STATES, March 7, 2025 /⁨EINPresswire.com⁩/ -- In an age where personal well-being and leadership go hand in hand, Sawatch Solutions, founded by seasoned technologist and wellness expert Keith Engelhardt, stands at the forefront, offering …

Silver Lining Clinics by MoodRx Sees Overwhelming Demand as Seniors Flock for Affordable Mental Health Therapy in PA

Silver Lining Clinics by MoodRx Sees Overwhelming Demand as Seniors Flock for Affordable Mental Health Therapy in PA

Unprecedented demand for Medicare-covered therapy drives rapid expansion of Silver Lining Clinics by MoodRx, ensuring seniors receive critical mental healthcare WAYNE, PA, UNITED STATES, March 7, 2025 /⁨EINPresswire.com⁩/ -- Silver Lining Clinics by …

Medical Second Opinion Market Set to Reach USD 24.18 Billion by 2032, at a CAGR of 16.5% | Coherent Market Insights

Medical Second Opinion Market Set to Reach USD 24.18 Billion by 2032, at a CAGR of 16.5% | Coherent Market Insights

The Medical Second Opinion Market is estimated to be valued at USD 8.30 Bn in 2025 and is expected to reach USD 24.18 Bn by 2032, growing at a CAGR of 16.5%. BURLINGAME, CA, UNITED STATES, March 7, 2025 /⁨EINPresswire.com⁩/ -- The Latest comprehensive …

U.S. Post-acute Care Market Set to Reach USD  668.37 Billion by 2032, at a CAGR of  7.3% | Coherent Market Insights

U.S. Post-acute Care Market Set to Reach USD 668.37 Billion by 2032, at a CAGR of 7.3% | Coherent Market Insights

The U.S. post-acute care market is estimated to be valued at USD 407.89 Bn in 2025 …

Cellectis to Report Fourth Quarter and Full Year 2024 Financial Results on March 13, 2025

Cellectis to Report Fourth Quarter and Full Year 2024 Financial Results on March 13, 2025

NEW YORK, March 07, 2025 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS- NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, today announced …

STIM1: the cancer shield against sorafenib unmasked

STIM1: the cancer shield against sorafenib unmasked

GA, UNITED STATES, March 7, 2025 /⁨EINPresswire.com⁩/ -- A recent study unveils how stromal interaction molecule 1 (STIM1), a protein involved in calcium signaling, plays a pivotal role in the resistance of liver cancer to sorafenib, a key treatment for …

Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

BEDFORD, Mass., March 07, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), a biopharmaceutical company committed to redefining the retina experience, today announced that it has granted inducement awards to one newly hired …

Replimune Announces Inducement Grants Under Nasdaq  Listing Rule 5635(c)(4)

Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

WOBURN, Mass., March 07, 2025 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced the grant of inducement equity awards to newly …

Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

DURHAM, N.C., March 07, 2025 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), today announced that on March 2, 2025, the Compensation Committee of Chimerix’s Board of Directors granted an inducement award to a new employee of non-statutory stock options to …

SS Innovations International Launches the 2nd Global Robotic Surgery Conference, SMRSC 2025

SS Innovations International Launches the 2nd Global Robotic Surgery Conference, SMRSC 2025

FORT LAUDERDALE, Fla., March 07, 2025 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (OTC: SSII) (“SS Innovations” or the “Company”), a developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery affordable …

Acral Lentiginous Melanoma Market to Reach USD 122.3 Million by 2033, Growing at 3.80% CAGR

Acral Lentiginous Melanoma Market to Reach USD 122.3 Million by 2033, Growing at 3.80% CAGR

Acral Lentiginous Melanoma Market was valued at USD 85 Million in 2023, and is expected to reach USD 122.3 Million in 2033, at a CAGR of 3.80% NEW YORK, NY, UNITED STATES, March 7, 2025 /⁨EINPresswire.com⁩/ -- The Global Acral Lentiginous Melanoma (ALM) …

Stretch Marks Treatment Market Set for 8.0% CAGR Growth, Surpassing USD 6.1 Billion

Stretch Marks Treatment Market Set for 8.0% CAGR Growth, Surpassing USD 6.1 Billion

Stretch Marks Treatment Market was valued at USD 2.9 billion in 2023. It is expected to reach USD 6.1 billion by 2033, with a CAGR of 8.0% NEW YORK, NY, UNITED STATES, March 6, 2025 /⁨EINPresswire.com⁩/ -- The Stretch Marks Treatment Market was valued at …

Generic Drug Market Size Will Achieve USD 795.68 Billion By 2032 – Data Analysis by Emergen Research

Generic Drug Market Size Will Achieve USD 795.68 Billion By 2032 – Data Analysis by Emergen Research

The global Generic Drug Market size was USD 360.84 Billion in 2022 and is expected to register a rapid revenue CAGR of 8.4% VANCOUVER, BC, CANADA, March 7, 2025 /⁨EINPresswire.com⁩/ -- The global Generic Drug Market size was USD 360.84 Billion in 2022 and …

Artax Biopharma Presents New Preclinical Data on Nck Modulators at 2025 AAD Annual Meeting

Artax Biopharma Presents New Preclinical Data on Nck Modulators at 2025 AAD Annual Meeting

Nck modulator reduced evidence of inflammation in an animal model of dermal irritation Compelling preclinical data support continued development of Nck modulators in atopic dermatitis CAMBRIDGE, Mass., March 07, 2025 (GLOBE NEWSWIRE) -- Artax Biopharma, …

Capricor Therapeutics to Present at Leerink’s Global Healthcare Conference 2025

Capricor Therapeutics to Present at Leerink’s Global Healthcare Conference 2025

SAN DIEGO, March 07, 2025 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, today announced that Capricor management will …

AskBio Advances Gene Therapy Clinical Trial for Limb-Girdle Muscular Dystrophy Type 2I/R9 with Dosing of First Participant in Second Cohort

AskBio Advances Gene Therapy Clinical Trial for Limb-Girdle Muscular Dystrophy Type 2I/R9 with Dosing of First Participant in Second Cohort

Research Triangle Park, N.C., March 07, 2025 (GLOBE NEWSWIRE) -- Data Safety Monitoring Board (DSMB) recommendation to initiate second cohort follows review of Phase 1/Phase 2 LION-CS101 trial safety data for AB-1003 Second cohort enrollment is ongoing …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service